Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Virtual Congress 2020

Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics

The regulatory perspective: How to look for certainty in terra incognita

Date

17 Oct 2020

Session

Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics

Topics

Bioethical Principles and GCP

Tumour Site

Presenters

Francesco Pignatti

Authors

F. Pignatti

Author affiliations

  • Office Of Oncology And Haematology, European Medicines Agency - Amsterdam, 1083 HN - Amsterdam/NL

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Q&A and live discussion

Presenter: Irene Braña

Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.